QLD vs. CURE
Compare and contrast key facts about ProShares Ultra QQQ (QLD) and Direxion Daily Healthcare Bull 3x Shares (CURE).
QLD and CURE are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. QLD is a passively managed fund by ProShares that tracks the performance of the NASDAQ-100 Index (200%). It was launched on Jun 21, 2006. CURE is a passively managed fund by Direxion that tracks the performance of the Health Care Select Sector Index (300%). It was launched on Jun 15, 2011. Both QLD and CURE are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: QLD or CURE.
Key characteristics
| QLD | CURE | |
|---|---|---|
| YTD Return | 7.74% | 3.78% |
| 1Y Return | 67.51% | 5.96% |
| 3Y Return (Ann) | 7.48% | 4.07% |
| 5Y Return (Ann) | 26.78% | 16.84% |
| 10Y Return (Ann) | 29.98% | 19.04% |
| Sharpe Ratio | 2.34 | 0.23 |
| Daily Std Dev | 32.70% | 31.45% |
| Max Drawdown | -83.13% | -69.19% |
| Current Drawdown | -10.76% | -26.56% |
Correlation
The correlation between QLD and CURE is 0.65, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
QLD vs. CURE - Performance Comparison
In the year-to-date period, QLD achieves a 7.74% return, which is significantly higher than CURE's 3.78% return. Over the past 10 years, QLD has outperformed CURE with an annualized return of 29.98%, while CURE has yielded a comparatively lower 19.04% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
QLD vs. CURE - Expense Ratio Comparison
QLD has a 0.95% expense ratio, which is lower than CURE's 1.08% expense ratio.
Risk-Adjusted Performance
QLD vs. CURE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra QQQ (QLD) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
QLD vs. CURE - Dividend Comparison
QLD's dividend yield for the trailing twelve months is around 0.38%, less than CURE's 1.82% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
QLD ProShares Ultra QQQ | 0.38% | 0.33% | 0.31% | 0.00% | 0.00% | 0.13% | 0.06% | 0.02% | 0.24% | 0.11% | 0.19% | 0.13% |
CURE Direxion Daily Healthcare Bull 3x Shares | 1.82% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% | 0.00% | 0.00% | 0.00% | 1.24% |
Drawdowns
QLD vs. CURE - Drawdown Comparison
The maximum QLD drawdown since its inception was -83.13%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for QLD and CURE. For additional features, visit the drawdowns tool.
Volatility
QLD vs. CURE - Volatility Comparison
ProShares Ultra QQQ (QLD) and Direxion Daily Healthcare Bull 3x Shares (CURE) have volatilities of 10.35% and 10.19%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.